Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:40 AM
Ignite Modification Date:
2025-12-25 @ 4:40 AM
NCT ID:
NCT03310918
Eligibility Criteria:
Inclusion Criteria:
* Patients with AML receiving non-intensive therapy including hypomethylating agents, single-agent chemotherapy, targeted therapy agents, or single or combination non-intensive agents offered on a clinical trial, including the following populations:
* Newly diagnosed AML
* Relapsed AML
* Primary refractory AML
* The ability to provide informed consent
* The ability to comprehend English or complete questionnaires with minimal assistance of an interpreter
Exclusion Criteria:
* Patients not receiving care at MGH
* Patients receiving intensive chemotherapy (requiring 4-6 week hospitalization)
* Patients receiving supportive care alone
* Major psychiatric illness or co-morbid conditions prohibiting compliance with study procedures
* Patients already receiving palliative care
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03310918
Study Brief:
Protocol Section:
NCT03310918